Gain Therapeutics GANX reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Gain Therapeutics missed estimated earnings by 38.71%, reporting an EPS of $-0.43 versus an estimate of $-0.31.
Revenue was up $5 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 0.0% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Gain Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.